This content was created by GHION.AI . This content was uploaded by GHION.AI . This is a YouTube video titled "The Evolution of Biotech" featuring a monologue by George Scangos discussing the advancements in biotechnology from the late 1990s to the present, highlighting the impact of CRISPR and data sciences on genetic research.
Chapters
Science has changed a lot. I mean, you know, even like, you know, conceptually, what we were doing at Exelixis in the late 90s, early 2000s is conceptually the same as a lot of the work we're doing at Veer now. Except back then we had to do these genetic analyses in fruit flies and C. Elegans and worms, and it would take six months to do an experiment. Today, you can do them directly in a mammalian system with CRISPR and get more and more and more relevant information in three weeks. And so the. And that's a combination of advances in biology and, you know, CRISPR and Jennifer down there who won the Nobel Prize on Sharpenergate and in data sciences, because you generate reams of data and you have to be able to make sense of it and parse through it, and there's too much to do in your head. So those two things have changed. There have been successes. You know, in the early days, it was easy things. It was insulin and just factors that you normally made and now could be made in system. They were easy. And as the understanding biology has gone on and things have gotten more sophisticated, you can do more challenging things. And there have been successes. So that means money has poured in. You have access to a level of resources now that was unheard of a decade ago.
